Understanding how certain RNA molecules can self-cleave
Structure-Activity Based Mechanistic Insights into Cleavage Chemistry by Self-Cleaving Nucleolytic Ribozymes
This study is looking at how tiny RNA molecules called ribozymes can cut themselves in specific ways, which could help us understand new treatments for diseases that involve RNA.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10876446 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which small RNA molecules, known as ribozymes, can cleave themselves at specific sites. By examining various types of ribozymes, the study aims to uncover the roles of different chemical components and structures in this self-cleavage process. The research employs advanced techniques such as crystallization and structure-function studies to analyze how these ribozymes operate at a molecular level. Patients may benefit from insights gained that could lead to new therapeutic approaches targeting RNA-based mechanisms in diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions related to RNA dysfunction or diseases where RNA plays a critical role.
Not a fit: Patients with conditions unrelated to RNA mechanisms or those not involving self-cleaving processes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that leverage RNA's self-cleaving abilities to target and regulate disease processes.
How similar studies have performed: Other research has shown promising results in understanding RNA mechanisms, suggesting that this approach could yield valuable insights, although the specific focus on self-cleaving ribozymes is relatively novel.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Patel, Dinshaw J — Sloan-Kettering Inst Can Research
- Study coordinator: Patel, Dinshaw J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.